Dr. Kellyann Niotis is a preventive neurologist specializing in risk reduction strategies for neurodegenerative disorders including Alzheimer’s disease, Lewy Body Dementia, and Parkinson’s disease. She leads the preventive neurology program within Dr. Peter Attia’s medical practice, Early Medical, focused on the applied science of longevity. Previously, she managed the country’s first Alzheimer's Prevention Clinic at Weill Cornell Medical College/NewYork-Presbyterian Hospital.
Race & Health Equity | MinnPost minnpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from minnpost.com Daily Mail and Mail on Sunday newspapers.
The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer s disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of
The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer s disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of